Montreal Chest Institute, McGill University

Montreal, Quebec H2X 2P4Pq Canada

0 studies enrolling now · 11 studies all time

What they study most

Asthma, HIV Infections, Pulmonary Tuberculosis, Tuberculosis

Studies at this site

• TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment — Completed
• Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection — Completed
• Asthma Intervention Research 2 (AIR2) Trial — Completed
• TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz — Completed
• TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance — Completed
• TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis — Completed
• TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine — Completed
• TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB — Completed
• TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB — Completed
• TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen — Completed
• TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis — Completed